Whittier Trust Co. of Nevada Inc. Has $1.08 Million Stock Holdings in Relx Plc $RELX

Whittier Trust Co. of Nevada Inc. lifted its holdings in Relx Plc (NYSE:RELX) by 54.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 19,941 shares of the technology company’s stock after buying an additional 7,057 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Relx were worth $1,084,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Goldman Sachs Group Inc. raised its holdings in shares of Relx by 4.5% in the first quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company’s stock valued at $205,287,000 after purchasing an additional 173,976 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of Relx by 8.3% in the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock valued at $154,129,000 after acquiring an additional 234,094 shares during the last quarter. Northern Trust Corp raised its holdings in Relx by 9.2% during the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock worth $120,686,000 after acquiring an additional 202,509 shares in the last quarter. Natixis Advisors LLC grew its stake in Relx by 0.5% in the first quarter. Natixis Advisors LLC now owns 1,208,467 shares of the technology company’s stock valued at $60,919,000 after purchasing an additional 5,875 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Relx by 103.4% during the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company’s stock worth $22,400,000 after purchasing an additional 225,947 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Relx Stock Performance

NYSE:RELX opened at $46.83 on Thursday. The stock’s 50-day simple moving average is $46.68 and its 200 day simple moving average is $50.55. The firm has a market capitalization of $85.57 billion, a PE ratio of 25.18, a price-to-earnings-growth ratio of 3.04 and a beta of 0.87. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55. Relx Plc has a twelve month low of $44.19 and a twelve month high of $56.33.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Kepler Capital Markets upgraded Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Wall Street Zen cut Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. Morgan Stanley restated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Barclays reaffirmed an “overweight” rating on shares of Relx in a report on Tuesday, October 7th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Relx in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the company. According to MarketBeat, Relx presently has a consensus rating of “Buy”.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.